Persistent expression of cytokine in the chronic stage of viral myocarditis in mice

Circulation

Volumn 94, Issue 11, 1996, Pages 2930-2937

  Shioi, Tetsuo ^a   Matsumori, Akira ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

cardiomyopathy; heart failure; interleukins; myocarditis; remodeling

Indexed keywords

CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHRONIC DISEASE; CONTROLLED STUDY; COXSACKIE VIRUS B; ENDOTHELIUM CELL; HEART DILATATION; IMMUNOREGULATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; VIRUS MYOCARDITIS;

EID: 0029797142     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2930     Document Type: Article

References (44)

1. MacArthur CGC, Tarin D, Goodwin JE, Hallidie-Smith KA. The relationship of myocarditis to dilated cardiomyopathy. Ear Heart J. 1984;5:1023-1035.
2. Parrillo JE, Aretz TH, Palacios I, Fallon JT, Block PC. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation. 1984;69:93-101.
3. Kawai C, Matsumori A, Fujuwara H. Myocarditis and dilated cardiomyopathy. Anna Rev Med. 1989;38:221-239.
4. Cambridge G, Macarthur CGC, Waterson AP, Goodwin JF, Oakley CM. Antibodies to coxsackie B viruses in primary congestive cardiomyopathy. Br Heart J. 1979;41:692-696.
5. Bowles NE, Richardson PJ, Olsen EGJ, Archard LC. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy, Lancet. 1986;1:1120-1123.
6. Bowles NE, Rose ML, Taylor P, Banner NR, Morgan-Capner P, Cunningham L, Archard LC, Yacoub MH. End-stage dilated cardiomyopathy: persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation. 1989;80:1128-1136.
7. Matsumori A, Kawai C. An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation. 1982;66:355-360.
8. Balkwill PR, Burke F. The cytokine network. Immunol Today. 1989;10:299-304.
9. Arai KJ, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783-836.
10. Yamada T, Matsumori A, Saxayama S. Therapeutic effect of antitumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarclitis virus. Circulation. 1994;89:846-851.
11. Smith SC, Allen PM, Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res. 1992;70:856-863.
12. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. Interleukin-1 or tumor necrosis factor can promote coxsackievirus B3-induced myocarditis in resistant B 10.A mice. J Exp Med. 1992;175:1123-1129.
13. Kyu B-S, Matsumori A, Sato Y, Okada I, Chapman NM, Tracy S. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of cardiomyopathy. Circulation. 1992;86:522-530.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidtnium thiocyanale-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
15. Gray PW, Goeddel DV. Cloning and expression of murine immune interferon cDNA. Proc Natl Acad Sci U S A. 1983;80:5842-5846.
16. Gray PW, Glaister D, Chen E, Goeddel DV, Pennica D. Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for the murine IL-1β. J Immunol. 1986;137:3644-3648.
17. Yokota T, Arai N, Lee F, Rennick D, Mosmann T, Arai K-I. Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: expression of T-cell growth-factor activity after transfection of monkey cells. Proc Natl Acad Sci U S A. 1985;82:68-72.
18. Pennica D, Hayflick JS, Bringham TS, Palladino MA, Goeddel DV. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci U S A. 1985;82:6060-6064.
19. Bae YS, Eun HM, Yoon JW. Genomic differences between diabetogenic and nondiabetogenic encephalomyocarditis virus. Virology. 1989;170:282-287.
20. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acids Res. 1986;14:2829.
21. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neural. 1993;33:576-582.
22. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995;146:419-428.
23. Furukawa Y, Matsumori A, Hirozane T, Sasayama S. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model, a comparative study with captopril. Circulation. 1996;93:333-339.
24. Jaattela M. Biology of disease: biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab Invest. 1991;64:724-742.
25. Kishimoto C, Kuribayashi K, Masuda T, Tomioka N, Kawai C. Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice. Circulation. 1985;71:1247-1254.
26. Kishimoto C, Kuribayashi K, Fukuma K, Masuda T, Tomioka N, Abelmann WH, Kawai C. Immunologic identification of lymphocyte subsets in experimental murine myocarditis with encephalomyocarditis virus. Circulation. 1987;61:715-725.
27. Taniguchi T, Regulation of cytokine gene expression. Annu Rev Immunol 1988;6:439-464.
28. Efrat S, Pilo S, Kaempfer R. Kinetics of induction and molecular size of mRN As encoding human interleukin-2 and gamma-interferon. Nature. 1982;297:236-239.
29. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res. 1994;75:278-284.
30. Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation. 1994;89:2421-2432.
31. Hosenpud JD, Campbell SM, Mendelson DJ, Interleukin-1-induced myocardial depression in an isolated beating heart preparation. J Heart Transplant. 1989;8:460-464.
32. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
33. Balligand J-L, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Smith TW, Michel T. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J din Invest. 1993;91:2314-2319.
34. Hosenpud JD. The effect of interleukin I on myocardial function and metabolism. Clin Immunol Immunopathol. 1993;68:175-180.
35. Libby P, Warner SJ, Friedman GB. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoid. J Clin Invest. 1988;81:487-498.
36. Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alternation in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding extracellular matrix components. Circ Res. 1994;75:23-32.
37. Thaik CM, Calderone A, Takahashi N, Colucci WS. Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest. 1995;96:1093-1099.
38. Woodley SL, McMillan M, Shelby J, Lynch DH, Roberts LK, Ensley RD, Barry WH. Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes. Circulation. 1991;83:1410-1418.
39. Seko Y, Ishiyama S, Nishikawa T, Kasajima T, Hiroe M, Kagawa N, Osada K, Suzuki S, Yagita H, Okumura K, Yazaki Y. Restricted usage of T cell receptor Vα-Vβ genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy. J Clin Invest. 1995;96:1035-1041.
40. Cunningham L, Bowles NE, Lane RJM, Dubowitz V, Archard LC. Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J Gen Virol. 1990;71:1399-1402.
41. Fohlman J, Friman G. Is juvenile diabetes a viral disease? Ann Med. 1993;25:569-574.
42. Bendtzen K, Mandnip-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science. 1986;232:1545-1547.
43. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol. 1987;18:619-624.
44. Dinarello CA. Modalities for reducing interleukin I activity in disease. Immunol Today. 1993;14:260-264.